Corin expands direct strategy to more markets
This article was originally published in Clinica
Executive Summary
UK reconstructive orthopaedic device company Corin is expanding its direct sales strategy to more international markets. Continuing the impetus that has seen the Cirencester-based company increase to 81% (from 67% in the first half of 2003) the share of its revenues derived from direct business - ie via its own subsidiaries and sales forces - Corin is planning to opt for the same model in China before the end of calendar 2004.